Adjuvant immunotherapy for solid tumors: from promise to clinical application Simone MocellinCarlo R. RossiFrancesco M. Marincola Review Pages: 583 - 595
Linomide administration following bone marrow transplantation in mice Lola WeissAli Abdul-HaiShimon Slavin Original Article Pages: 596 - 602
41.8°C whole body hyperthermia as an adjunct to chemotherapy induces prolonged T cell activation in patients with various malignant diseases Djordje AtanackovicAxel NierhausSusanna Hegewisch-Becker Original Article Pages: 603 - 613
Enhanced induction of human WT1-specific cytotoxic T lymphocytes with a 9-mer WT1 peptide modified at HLA-A*2402-binding residues Akihiro TsuboiYoshihiro OkaHaruo Sugiyama Original Article Pages: 614 - 620
Efficient carcinoma cell killing by activated polymorphonuclear neutrophils targeted with an Ep-CAM×CD64 (HEA125×197) bispecific antibody Christof SchweizerGudrun StraussGerhard Moldenhauer Original Article Pages: 621 - 629
Phase I/II study of sequential chemoimmunotherapy (SCIT) for metastatic melanoma: outpatient treatment with dacarbazine, granulocyte-macrophage colony-stimulating factor, low-dose interleukin-2, and interferon-alpha Gerard GroenewegenAndries BloemGijsbert C. de Gast Original Article Pages: 630 - 636
Therapeutic vaccination against metastatic renal cell carcinoma by autologous dendritic cells: preclinical results and outcome of a first clinical phase I/II trial Angela MärtenDimitri FliegerIngo G. Schmidt-Wolf Original Article Pages: 637 - 644
The combination of a chemokine, cytokine and TCR-based T cell stimulus for effective gene therapy of cancer Stephane PaulEtienne RegulierBruce R. Acres Original Article Pages: 645 - 654
Analysis of the antibody repertoire of lymphoma patients Shaoming HuangKlaus-Dieter PreussMichael Pfreundschuh Original Article Pages: 655 - 662
Calcitonin-specific antitumor immunity in medullary thyroid carcinoma following dendritic cell vaccination Matthias SchottJoachim FeldkampJochen Seissler Original Article Pages: 663 - 668
Mucin gene (MUC1) transfected dendritic cells as vaccine: results of a phase I/II clinical trial Gabriele PecherArnt HäringEckhard Thiel Original Article Pages: 669 - 673
Synopsis of the 4th Walker's Cay Meeting on Cancer Vaccines, 7–10 March 2002 Malcolm S. MitchellMartin W. Kast Symposium Series Pages: 674 - 676
